| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
other |
Short-Term Biomarkers of Tumor Promotion in Mouse Skin Treated with Petroleum Middle Distillates1





*Dermigen, Inc. P.O. Box 727, Smithville, Texas 78957
University of Texas M.D. Anderson Cancer Center, Science Park-Research Division P.O. Box 389, Smithville, Texas 78957
Exxon Biomedical Sciences, Inc. CN-2350, Mettlers Road, East Millstone, New Jersey 08875
Shell Oil Company P.O. Box 4320, Houston, Texas 77210
||Pennzoil Company P.O. Box 2967, Houston, Texas 77252
Received December 31, 1997; accepted July 2, 1998
Topical application of certain petroleum middle distillates (PMD) to mice produces skin tumors after long latency, and initiation/promotion protocols indicate that effect is associated with their tumor promoting activity. Since induction of sustained, potentiated epidermal hyperplasia is predictive of promoting activity, five compositionally distinct PMD [hydrodesulfurized kerosene (API 81-70); hydrodesulfurized PMD (API 81-10); odorless light petroleum hydrocarbons; severely hydrotreated light vacuum distillate (LVD); and lightly refined paraffinic oil (LRPO)] were assessed for their effects on epidermal hyperplasia PMD were administered (2 x/week for 2 weeks) to skin of CD-1 mice Four quantitative biomarkers of epidermal hyperplasia were evaluated: epidermal thickness, number of nucleated epidermal cells per unit length of basement membrane, labeling (BrdUrd) index of epidermal cells, and induction of epidermal ornithine decarboxylase (ODC) activity. As positive controls, 12-O-tetradecanoylphorbol-13-acetate (TPA) and n-dodecane were utilized. PMD-induced skin irritation was evaluated visually and/or histopathologically. All five PMD produced dose-dependent, skin irritation and epidermal hyperplasia. On a weight basis the magnitude of the maximal PMD-induced effects was similar to that produced by n-dodecane, but >1000-fold less than that produced by TPA. Epidermal hyperplasia and subacute skin irritancy produced by the five PMD were similar. Of the four short-term markers of tumor promotion assessed, labeling index and epidermal ODC activity were predictive of the relative promoting activities of those PMD for which tumorigenicity bioassay data are available, i.e, API 81-07 > API 81-10 > LRPO. An apparent discrepancy to the predictability of epidermal ODC activity occurred with LRPO:toluene [1:1(v/v)]. This mixture is nontumorigenic, yet significantly induced epidermal ODC activity. This mixture, however, produced severe epidermal toxicity that precluded any meaningful analysis of short-term biomarkers in relationship to biological activity.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. N. McDougal, C. M. Garrett, C. M. Amato, and S. J. Berberich Effects of Brief Cutaneous JP-8 Jet Fuel Exposures on Time Course of Gene Expression in the Epidermis Toxicol. Sci., February 1, 2007; 95(2): 495 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, R. Zoltaszek, J. E. Swauger, A. T. Mosberg, and T. J. Slaga Short-Term Biomarkers of Cigarette Smoke Condensate Tumor Promoting Potential in Mouse Skin Toxicol. Sci., January 1, 2006; 89(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, A. T. Mosberg, and T. J. Slaga Short-Term In Vitro and In Vivo Analyses for Assessing the Tumor-Promoting Potentials of Cigarette Smoke Condensates Toxicol. Sci., September 1, 2004; 81(1): 14 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Babu, A Chatterjee, E Ahaghotu, and M Singh Percutaneous absorption and skin irritation upon low-level prolonged dermal exposure to nonane, dodecane and tetradecane in hairless rats Toxicology and Industrial Health, July 1, 2004; 20(6-10): 109 - 118. [Abstract] [PDF] |
||||
![]() |
M. Hanausek, Z. Walaszek, A. Viaje, M. LaBate, E. Spears, D. Farrell, R. Henrich, A. Tveit, E. F. Walborg Jr, and T. J. Slaga Exposure of mouse skin to organic peroxides: subchronic effects related to carcinogenic potential Carcinogenesis, March 1, 2004; 25(3): 431 - 437. [Abstract] [Full Text] [PDF] |
||||


